Gold nanoparticle–M2e conjugate coformulated with CpG induces protective immunity against influenza A virus

Immunization with M2e-Displaying T7 Bacteriophage Nanoparticles Protects against Influenza A Virus Challenge

(2012) Hamidreza Hashemi et al.   PLoS One

A gold nanoparticle-based immunochromatographic assay: The influence of nanoparticulate size

(2011) Sha Lou et al.   ANALYST

Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment

(2011) Anil Kumar et al.   BIOMATERIALS

Gold nanoparticles in biomedical applications: recent advances and perspectives

(2011) Lev Dykman et al.   CHEMICAL SOCIETY REVIEWS

Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity

(2011) Jae-Min Song et al.   PLoS One

α-Galactosylceramide potently augments M2e-induced protective immunity against highly pathogenic H5N1 avian influenza virus infection in mice

(2011) Kai Li et al.   VACCINE

Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice

(2010) C. Lasagna-Reeves et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Multifunctionalized Gold Nanoparticles with Peptides Targeted to Gastrin-Releasing Peptide Receptor of a Tumor Cell Line

(2010) Leticia Hosta-Rigau et al.   BIOCONJUGATE CHEMISTRY

Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies

(2010) Nikolai Khlebtsov et al.   CHEMICAL SOCIETY REVIEWS

Gold nanoparticle platforms as drug and biomacromolecule delivery systems

(2010) Bradley Duncan et al.   JOURNAL OF CONTROLLED RELEASE

Preparation of surfactant-stabilized gold nanoparticle–peptide nucleic acid conjugates

(2010) Janice Duy et al.   JOURNAL OF NANOPARTICLE RESEARCH

Targeting Nanosystems to Human DCs via Fc Receptor as an Effective Strategy to Deliver Antigen for Immunotherapy

(2010) Luis J. Cruz et al.   MOLECULAR PHARMACEUTICS

Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide

(2010) Yu-Shiun Chen et al.   NANOTECHNOLOGY

An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses

(2010) Guangyu Zhao et al.   Virology Journal

Influenza A viruses: why focusing on M2e-based universal vaccines

(2010) Seyyed Mahmoud Ebrahimi et al.   VIRUS GENES

Strategies and Limitations in Dendrimeric Immunogen Synthesis. The Influenza Virus M2e Epitope as a Case Study

(2009) Wioleta Kowalczyk et al.   BIOCONJUGATE CHEMISTRY

Assessment of the In Vivo Toxicity of Gold Nanoparticles

(2009) Yu-Shiun Chen et al.   Nanoscale Research Letters

Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles

(2009) Wan-Seob Cho et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys

(2009) Tong-Ming Fu et al.   VACCINE

The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine

(2009) Fan Wu et al.   VACCINE

Gold Nanoparticles in Biology: Beyond Toxicity to Cellular Imaging

(2008) Catherine J. Murphy et al.   ACCOUNTS OF CHEMICAL RESEARCH

Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size

(2008) Ganeshchandra Sonavane et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

ICP-MS: a powerful technique for quantitative determination of gold nanoparticles without previous dissolving

(2008) R. Allabashi et al.   JOURNAL OF NANOPARTICLE RESEARCH

Peptides conjugated to gold nanoparticles induce macrophage activation

(2008) Neus G. Bastús et al.   MOLECULAR IMMUNOLOGY

Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies

(2008) Marina De Filette et al.   VACCINE

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

(2007) James W. Huleatt et al.   VACCINE